Edelweiss Mutual Fund
← All mutual funds

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Direct Plan - Growth

Edelweiss Mutual Fund · Index Funds · Direct · Growth

NAV · as of 10/09/2026

24.52

1D

-0.43%

1Y

+20.16%

Key stats

Expense ratio
0.54%
AUM
₹195.40 Cr
Launched
26/10/2020
Fund manager
Bhavesh Jain; Amit Vora; Manasi Jalgaonkar
Portfolio turnover
0.12%
Risk
Very High Risk
Min lump-sum
₹100
Min SIP
₹100/mo
Fresh lump-sum
Closed
Fresh SIP
Closed
Max per purchase
₹1,00,000

NAV history

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Direct Plan - Growth

11/08/2026 to 10/09/2026

O - H - L -

25.2024.5211/08/202610/09/2026
1W-1.51%
1M-1.38%
3M+7.61%
6M+12.70%
1Y+20.16%
3Y+18.84%
5Y+13.52%
MAX+145.36%

Top holdings

47 disclosed
  • 1.

    Sun Pharmaceuticals Industries Ltd

    Healthcare

    11.30%
  • 2.

    Eli Lilly and Co

    Healthcare

    6.43%
  • 3.

    Divi's Laboratories Ltd

    Healthcare

    6.07%
  • 4.

    Apollo Hospitals Enterprise Ltd

    Healthcare

    5.69%
  • 5.

    Max Healthcare Institute Ltd Ordinary Shares

    Healthcare

    4.89%
  • 6.

    Cipla Ltd

    Healthcare

    4.69%
  • 7.

    Torrent Pharmaceuticals Ltd

    Healthcare

    4.61%
  • 8.

    Johnson & Johnson

    Healthcare

    4.30%
  • 9.

    Laurus Labs Ltd

    Healthcare

    4.02%
  • 10.

    Dr Reddy's Laboratories Ltd

    Healthcare

    3.63%
  • 11.

    Lupin Ltd

    Healthcare

    3.48%
  • 12.

    AbbVie Inc

    Healthcare

    3.09%
  • 13.

    Fortis Healthcare Ltd

    Healthcare

    2.93%
  • 14.

    Aurobindo Pharma Ltd

    Healthcare

    2.61%
  • 15.

    Merck & Co Inc

    Healthcare

    2.24%
  • 16.

    Novartis AG ADR

    Healthcare

    1.99%
  • 17.

    Glenmark Pharmaceuticals Ltd

    Healthcare

    1.99%
  • 18.

    Biocon Ltd

    Healthcare

    1.74%
  • 19.

    Mankind Pharma Ltd

    Healthcare

    1.61%
  • 20.

    Ipca Laboratories Ltd

    Healthcare

    1.54%
  • 21.

    Alkem Laboratories Ltd

    Healthcare

    1.52%
  • 22.

    Thermo Fisher Scientific Inc

    Healthcare

    1.49%
  • 23.

    Amgen Inc

    Healthcare

    1.45%
  • 24.

    Zydus Lifesciences Ltd

    Healthcare

    1.32%
  • 25.

    Abbott Laboratories

    Healthcare

    1.28%
  • 26.

    Aster DM Quality Care Ltd Ordinary Shares

    Healthcare

    1.21%
  • 27.

    Gland Pharma Ltd

    Healthcare

    1.17%
  • 28.

    Gilead Sciences Inc

    Healthcare

    1.13%
  • 29.

    Novo Nordisk AS ADR

    Healthcare

    1.06%
  • 30.

    Ajanta Pharma Ltd

    Healthcare

    0.96%
  • 31.

    Intuitive Surgical Inc

    Healthcare

    0.87%
  • 32.

    Danaher Corp

    Healthcare

    0.87%
  • 33.

    Vertex Pharmaceuticals Inc

    Healthcare

    0.84%
  • 34.

    Stryker Corp

    Healthcare

    0.78%
  • 35.

    Narayana Hrudayalaya Ltd

    Healthcare

    0.78%
  • 36.

    Medtronic PLC

    Healthcare

    0.76%
  • 37.

    Global Health Ltd

    Healthcare

    0.71%
  • 38.

    GlaxoSmithKline Pharmaceuticals Ltd

    Healthcare

    0.64%
  • 39.

    Regeneron Pharmaceuticals Inc

    Healthcare

    0.55%
  • 40.

    Anthem Biosciences Ltd

    Healthcare

    0.44%
  • 41.

    Becton Dickinson & Co

    Healthcare

    0.33%
  • 42.

    IQVIA Holdings Inc

    Healthcare

    0.28%
  • 43.

    Agilent Technologies Inc

    Healthcare

    0.27%
  • 44.

    Waters Corp

    Healthcare

    0.26%
  • 45.

    Net Receivables/(Payables)

    0.15%
  • 46.

    Clearing Corporation Of India Ltd.

    0.05%
  • 47.

    Accrued Interest

    0.00%

Sector allocation

  • Healthcare99.80%
  • Unclassified0.20%

Comparable peers

  • ICICI Prudential Nifty Pharma Index Growth Direct Plan

    ICICI Pru Nifty Pharma Index (G) · ₹147.90 Cr AUM

    1Y+21.17%
    3Y+20.55%
    -

  • Edelweiss MSCI India Domestic & World Healthcare 45 Index Growth Direct Plan

    Edelweiss MSCI India Domestic & World Healthcare 45 Index (G) · ₹195.40 Cr AUM

    1Y+20.16%
    3Y+19.13%
    -

  • UTI Nifty 500 Value 50 Index Growth Direct Plan

    UTI Nifty 500 Value 50 Index (G) · ₹846.20 Cr AUM

    1Y+14.63%
    3Y+21.95%
    -

  • Motilal Oswal BSE Enhanced Value Index Growth Direct Plan

    Motilal Oswal BSE Enhanced Value Index (G) · ₹2.22 K Cr AUM

    1Y+10.12%
    3Y+20.25%
    -

  • ICICI Prudential Nifty Auto Index Growth Direct Plan

    ICICI Pru Nifty Auto Index (G) · ₹242.30 Cr AUM

    1Y+2.42%
    3Y+20.30%
    -

Investment objective

The Scheme will invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. However, there is no assurance that the investment objective of the Scheme will be realized and the Scheme does not assure or guarantee any returns.

Scheme details

Scheme code
148555
Fund house
Edelweiss Mutual Fund
Category
Open Ended
Type
Other Scheme
Sub-category
Index Funds
Plan
Direct
Return type
Growth
ISIN (Growth)
INF754K01LV5
ISIN (Div. Reinvest)
-
Tradable on exchange
No

Kuvera page